Shopping Cart
- Remove All
- Your shopping cart is currently empty
TTX-080 is a human monoclonal antagonistic antibody targeting human leukocyte antigen G (HLA-G). By neutralizing HLA-G mediated immune suppression, TTX-080 exhibits antitumor activity. It holds potential for use in research involving solid tumors such as metastatic colorectal cancer (mCRC) and metastatic head and neck squamous cell carcinoma (mHNSCC).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | TTX-080 is a human monoclonal antagonistic antibody targeting human leukocyte antigen G (HLA-G). By neutralizing HLA-G mediated immune suppression, TTX-080 exhibits antitumor activity. It holds potential for use in research involving solid tumors such as metastatic colorectal cancer (mCRC) and metastatic head and neck squamous cell carcinoma (mHNSCC). |
Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.